跳至主要内容
临床试验/NL-OMON27198
NL-OMON27198已完成不适用

A randomized, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexate.

Millennium Pharmaceuticals Inc.0 个研究点目标入组 186 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
186

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age 18-70;
  • 2. Meeting ACR criteria for RA;

排除标准

  • 1. Use of any other DMARDS than MTX concomitantly or within one month prior to enrollment (in case of leflunomide, 3 months prior to enrollment or washout with cholestyramine);
  • 2. Currently being treated with TNF-antagonists or other biologicals (washout period 8 weeks);

研究者

相似试验

进行中(未招募)
1 期
A study investigating the efficacy and safety of 2 doses of NuSepin® intravenous infusion in adult subjects with Covid-19 pneumoniaAdult subjects with Covid-19 pneumonia
EUCTR2020-003107-34-ROShaperon Inc60
进行中(未招募)
1 期
A randomized, double blind, placebo controlled, phase II, multi-centre pilot study to investigate the effects of vitamin D2 or D3 supplementation on metabolic parameters in people at risk of type 2 diabetes. - Vitamin D Supplementation in People at Risk of Type 2 Diabetes V1.3
EUCTR2009-011264-11-GBQueen Mary University of London340
进行中(未招募)
不适用
A randomized, double blind, placebo controlled, phase II, dose-titration trial to explore the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatremia.Cirrhotic subjects with ascites and hypo- or normonatraemiaMedDRA version: 9.1Level: LLTClassification code 10009213Term: Cirrhosis of liverMedDRA version: 9.1Level: LLTClassification code 10003445Term: AscitesMedDRA version: 9.1Level: LLTClassification code 10021038Term: Hyponatremia
EUCTR2007-001711-31-DEMovetis NV12
进行中(未招募)
不适用
A randomized, double blind, placebo controlled, phase II, dose-titration trial to explore the safety, tolerability, pharmacokinetic profile and efficacy of M0002 in cirrhotic subjects with ascites and hypo- or normonatraemia.Cirrhotic subjects with ascites and hyponatremiaMedDRA version: 9.1Level: LLTClassification code 10009213Term: Cirrhosis of liverMedDRA version: 9.1Level: LLTClassification code 10003445Term: AscitesMedDRA version: 9.1Level: LLTClassification code 10021038Term: Hyponatremia
EUCTR2007-001711-31-BEMovetis NV18
已完成
不适用
Phase I study to assess the pharmacokinetics and pharmacodynamics of macitentan in Korean healthy male subjectsDiseases of the circulatory system
KCT0000326Actelion Pharmaceuticals Korea30